The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.
Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
Recognition, Diagnosis, and Management of Heart Failure with Preserved Ejection Fraction
Citation:
US Cardiology Review 2018;12(1):8–12.
1543
0
Excess Body Weight and Coronary Artery Disease - Associated Risks, the Obesity Paradox, and Implications for Cardiac Rehabilitation
Citation:
US Cardiology 2011;8(2):88–93
503
0
The Million Hearts Initiative - Targeting Key Drivers of Cardiovascular Mortality from a Medical Specialty Society Perspective
Citation:
US Cardiology 2012;9(1):66-70
385
0
Upstream Treatments for Atrial Fibrillation
Citation:
US Cardiology 2007;4(1):20–2
147
0
